Dasatinib inhibits PD-L1 expression via a proteasomal pathway in pancreatic ductal adenocarcinoma cells
Ching‐Chung Ko(National Sun Yat-sen University), Pei‐Ming Yang(Wan Fang Hospital)
Cited by 0
Related Papers
Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells
|Biomolecules|2020|64
A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine
|Scientific Reports|2014|47
Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner
|Biomolecules|2020|41
In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells
|Biomolecules|2019|32
Long Non-Coding RNA MIR31HG Promotes the Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma Cells
|International Journal of Molecular Sciences|2022|13